Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $14.87 $19.38 Friday, 10th May 2024 RGNX stock ended at $15.44. This is 1.53% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 10.42% from a day low at $14.87 to a day high of $16.42.
90 days $14.87 $28.80
52 weeks $11.83 $28.80

Historical REGENXBIO Inc. prices

Date Open High Low Close Volume
Nov 09, 2023 $17.04 $17.73 $16.49 $16.81 951 158
Nov 08, 2023 $16.50 $16.84 $16.01 $16.41 577 483
Nov 07, 2023 $15.86 $16.48 $15.74 $16.44 710 200
Nov 06, 2023 $15.52 $15.88 $15.01 $15.79 435 562
Nov 03, 2023 $14.36 $15.44 $14.36 $15.33 580 000
Nov 02, 2023 $14.18 $14.44 $13.57 $14.19 489 679
Nov 01, 2023 $13.26 $14.23 $12.85 $14.19 693 845
Oct 31, 2023 $13.60 $13.60 $12.82 $12.89 966 435
Oct 30, 2023 $14.57 $14.86 $14.32 $14.37 330 781
Oct 27, 2023 $15.42 $15.42 $14.33 $14.38 338 281
Oct 26, 2023 $15.59 $15.73 $15.27 $15.35 407 470
Oct 25, 2023 $15.73 $15.96 $15.49 $15.57 210 565
Oct 24, 2023 $15.75 $16.24 $15.72 $15.91 263 742
Oct 23, 2023 $15.99 $16.12 $15.55 $15.57 443 908
Oct 20, 2023 $15.99 $16.30 $15.80 $16.16 353 275
Oct 19, 2023 $16.06 $16.33 $15.85 $15.91 413 575
Oct 18, 2023 $16.36 $16.54 $15.87 $15.98 412 644
Oct 17, 2023 $16.10 $16.81 $16.10 $16.51 387 619
Oct 16, 2023 $16.15 $16.47 $15.85 $16.25 267 850
Oct 13, 2023 $15.95 $16.21 $15.78 $16.09 301 769
Oct 12, 2023 $16.80 $16.82 $15.90 $15.91 418 032
Oct 11, 2023 $16.80 $17.15 $16.61 $16.81 194 971
Oct 10, 2023 $16.06 $17.06 $16.06 $16.82 296 756
Oct 09, 2023 $15.73 $16.20 $15.43 $16.07 335 001
Oct 06, 2023 $15.87 $16.08 $15.46 $15.89 346 221
Click to get the best stock tips daily for free!

About REGENXBIO Inc.

REGENXBIO. REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's lead product candidate is RGX-314, wh... RGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT